GHC vs. APYX

In the year-to-date period, GHC achieves a 9.89% return, which is significantly higher than APYX's -1.27% return. Over the past 10 years, GHC has outperformed APYX with an annualized return of 5.07%, while APYX has yielded a comparatively lower -5.16% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GHC Sharpe Ratio is 0.96, which is higher than the APYX Sharpe Ratio of -0.03. The chart below compares the historical Sharpe Ratios of GHC and APYX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GHC's dividend yield for the trailing twelve months is around 0.74%, while APYX has not paid dividends to shareholders.

The maximum GHC drawdown since its inception was -67.54%, smaller than the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for GHC and APYX.

The current volatility for Graham Holdings Company (GHC) is 5.80%, while Apyx Medical Corporation (APYX) has a volatility of 50.96%. This indicates that GHC experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Graham Holdings Company and Apyx Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.